TNFRSF14 and non-Hodgkin lymphoma: Three cis-pQTL coding for higher TNFRSF14 were associated with a lower risk of NHL after correction for multiple testing (p < 0.05/939 tests based on cis-pQTL variants), 1:2559766:C:T [0.85 (0.79–0.91)]; 1:2559503:C:A, [0.85 (0.79–0.91)] and 1:2556714:A:G [0.86 (0.80–0.92)] (Fig. 4).